Streetbeat News

Products Services

VMC

Vulcan Materials (VMC) has provided its financial outlook for 2024, expecting net earnings between $0.95 billion and $1.07 billion, and adjusted EBITDA between $2 billion and $2.15 billion. Despite weather disruptions affecting construction activity and operating efficiencies, the company anticipates continued improvement in aggregates cash gross profit per ton and a positive pricing environment.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:50 am

JOBY

Joby Aviation shares are trading higher after the company announced it has formally applied for its revolutionary aircraft to be certified for use in Australia.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:49 am

FWRG

First Watch Restaurant confirms its FY24 total revenue growth of 17.0% to 19.0%, with adjusted EBITDA expected to be between $106.0 million and $112.0 million. The company plans capital expenditures of $125.0 million to $135.0 million, primarily for new restaurant projects and remodels.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:43 am

TSLA

Tesla Inc (NASDAQ:TSLA) is partnering with Costco to sell its electric vehicles in Taiwan from Aug. 5 to Aug. 18. The first 50 buyers will receive 5,000 km of free supercharger miles and a type 2 charger case for travel. This initiative aims to boost Tesla's sales in Taiwan, where it offers models like the Model 3 and Model Y.

Portfolio Pulse from Anan Ashraf

August 06, 2024 | 11:28 am

SPNS

Sapiens ReinsurancePro has been chosen by Rockford Mutual Insurance to improve efficiency and reduce claims leakage. This automation aims to ensure financial stability and operational excellence for the reinsurer.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:22 am

ELEV

Elevation Oncology has reported initial data from the dose escalation portion of its ongoing Phase 1 clinical trial of EO-3021. The trial showed a 42.8% confirmed objective response rate (ORR) in a subset of patients with Claudin 18.2-enriched gastric and GEJ cancer. The company observed minimal MMAE-associated toxicities and plans to advance into monotherapy dose expansion and combination cohorts, with additional data expected in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:18 am

PLTR

Palantir Technologies Inc. (NYSE:PLTR) reported an 83% YoY surge in U.S. commercial customers, attributing the growth to its boot camps and pilot programs. The company plans to continue leveraging these programs to attract new customers and transition them from prototype to production. Palantir's Q2 earnings beat revenue and EPS estimates, showing a 41% increase in customer count and a 55% YoY increase in U.S. commercial revenue. Analyst Dan Ives called the performance a 'game changer quarter,' highlighting Palantir's strong position in the AI market.

Portfolio Pulse from Ananya Gairola

August 06, 2024 | 11:15 am

OKYO

OKYO Pharma has been granted a European patent for its novel OK-101 chemerin analogs, enhancing its intellectual property portfolio.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:09 am

PMN

ProMIS Neurosciences Inc. (NASDAQ:PMN) has published two papers highlighting the role of toxic misfolded superoxide dismutase-1 (SOD1) aggregates in the pathogenesis of ALS. The research supports targeting misfolded proteins as a therapeutic strategy for ALS and potentially other neurodegenerative diseases.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:07 am

GRMN

Garmin has announced that customers can now make purchases in the Connect IQ Store using Garmin Pay. This new feature aims to enhance user convenience and streamline the purchasing process within the Garmin ecosystem.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:59 am